DAYLI Partners
Seoul-based venture capital firm founded in 2018, specializing in bio-healthcare and financials-governance sector investments.
Seoul, South Korea · 6+ investments · 11 portfolio companies
- Headquarters
- Seoul, South Korea
- Founded
- 2018
- Website
- dayli.partners
- Portfolio Companies
- 11
- Total Investments
- 6
- Last Investment
- Sep 2024
- Geographic Focus
- South Korea
Investment Thesis
DAYLI Partners is a Venture Capital firm based in Seoul, South Korea. It has made 6 investments, including Elisigen, 3D Medivision and Ranelagh. Focus areas include Biotech and Healthcare.
Portfolio11
Co-investors24
Sign up to view co-investors
24 co-investors across 27 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×17 · Corporate VC ×4 · Accelerator ×2 · 17 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/dayli-partners"><img src="https://indexed.vc/api/badge/investor/dayli-partners" alt="DAYLI Partners on Indexed.vc" width="260" height="76" /></a>